vs
Side-by-side financial comparison of ECB Bancorp, Inc. (ECBK) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $9.5M, roughly 1.4× ECB Bancorp, Inc.). ECB Bancorp, Inc. runs the higher net margin — 27.3% vs -73.9%, a 101.2% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 33.8%). ECB Bancorp, Inc. produced more free cash flow last quarter ($9.0M vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 23.8%).
ECB Bancorp, Inc. (MD) is a US-based bank holding company. It offers a full suite of retail and commercial banking products including deposit accounts, consumer loans, commercial financing and wealth management solutions, primarily serving individuals and small-to-mid enterprises across local markets in Maryland.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
ECBK vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $13.2M |
| Net Profit | $2.6M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | 36.7% | -24.8% |
| Net Margin | 27.3% | -73.9% |
| Revenue YoY | 33.8% | 59.8% |
| Net Profit YoY | 79.5% | 3.5% |
| EPS (diluted) | $0.32 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.5M | $13.2M | ||
| Q3 25 | $8.8M | $11.6M | ||
| Q2 25 | $8.0M | $11.2M | ||
| Q1 25 | $6.9M | $9.2M | ||
| Q4 24 | $7.1M | $8.3M | ||
| Q3 24 | $6.6M | $7.3M | ||
| Q2 24 | $6.3M | $7.4M | ||
| Q1 24 | $6.2M | $6.5M |
| Q4 25 | $2.6M | $-9.8M | ||
| Q3 25 | $2.4M | $-10.8M | ||
| Q2 25 | $1.4M | $-8.3M | ||
| Q1 25 | $1.3M | $-10.4M | ||
| Q4 24 | $1.4M | $-10.1M | ||
| Q3 24 | $1.1M | $-2.4M | ||
| Q2 24 | $791.0K | $-4.3M | ||
| Q1 24 | $621.0K | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | 36.7% | -24.8% | ||
| Q3 25 | 37.0% | -77.9% | ||
| Q2 25 | 23.9% | -65.4% | ||
| Q1 25 | 24.9% | -79.9% | ||
| Q4 24 | 27.3% | -91.8% | ||
| Q3 24 | 23.3% | -118.9% | ||
| Q2 24 | 16.9% | -111.0% | ||
| Q1 24 | 13.4% | -180.8% |
| Q4 25 | 27.3% | -73.9% | ||
| Q3 25 | 27.7% | -93.5% | ||
| Q2 25 | 18.0% | -73.9% | ||
| Q1 25 | 18.7% | -113.2% | ||
| Q4 24 | 20.3% | -122.4% | ||
| Q3 24 | 17.2% | -32.6% | ||
| Q2 24 | 12.6% | -58.8% | ||
| Q1 24 | 10.0% | -204.5% |
| Q4 25 | $0.32 | $-0.22 | ||
| Q3 25 | $0.29 | $-0.96 | ||
| Q2 25 | $0.17 | $-0.27 | ||
| Q1 25 | $0.16 | $-0.39 | ||
| Q4 24 | $0.18 | $-0.38 | ||
| Q3 24 | $0.14 | $-0.12 | ||
| Q2 24 | $0.09 | $-0.21 | ||
| Q1 24 | $0.07 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $82.8M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $171.9M | $-33.9M |
| Total Assets | $1.6B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $82.8M | $20.4M | ||
| Q3 25 | $201.9M | $22.7M | ||
| Q2 25 | $191.0M | $26.5M | ||
| Q1 25 | $143.7M | $13.0M | ||
| Q4 24 | $309.4M | $8.5M | ||
| Q3 24 | $114.8M | $11.3M | ||
| Q2 24 | $108.7M | $16.5M | ||
| Q1 24 | $109.8M | $4.0M |
| Q4 25 | $171.9M | $-33.9M | ||
| Q3 25 | $169.3M | $-26.7M | ||
| Q2 25 | $168.3M | $-19.4M | ||
| Q1 25 | $168.6M | $-34.4M | ||
| Q4 24 | $168.3M | $-25.9M | ||
| Q3 24 | $166.0M | $-20.4M | ||
| Q2 24 | $166.5M | $-25.3M | ||
| Q1 24 | $165.8M | $-36.0M |
| Q4 25 | $1.6B | $35.3M | ||
| Q3 25 | $1.6B | $36.5M | ||
| Q2 25 | $1.5B | $41.3M | ||
| Q1 25 | $1.5B | $28.6M | ||
| Q4 24 | $1.4B | $24.0M | ||
| Q3 24 | $1.4B | $27.5M | ||
| Q2 24 | $1.3B | $32.4M | ||
| Q1 24 | $1.3B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.2M | $-2.5M |
| Free Cash FlowOCF − Capex | $9.0M | $-2.5M |
| FCF MarginFCF / Revenue | 94.7% | -19.1% |
| Capex IntensityCapex / Revenue | 2.2% | 0.3% |
| Cash ConversionOCF / Net Profit | 3.55× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.2M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.2M | $-2.5M | ||
| Q3 25 | $4.0M | $-3.7M | ||
| Q2 25 | $1.9M | $-7.3M | ||
| Q1 25 | $-631.0K | $-4.5M | ||
| Q4 24 | $6.2M | $-5.7M | ||
| Q3 24 | $861.0K | $-10.8M | ||
| Q2 24 | $1.4M | $-13.4M | ||
| Q1 24 | $-429.0K | $-10.9M |
| Q4 25 | $9.0M | $-2.5M | ||
| Q3 25 | $4.0M | $-3.9M | ||
| Q2 25 | $1.8M | $-7.4M | ||
| Q1 25 | $-649.0K | $-5.3M | ||
| Q4 24 | $6.2M | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | $1.3M | $-13.5M | ||
| Q1 24 | $-449.0K | $-10.9M |
| Q4 25 | 94.7% | -19.1% | ||
| Q3 25 | 44.9% | -33.9% | ||
| Q2 25 | 23.0% | -66.1% | ||
| Q1 25 | -9.4% | -57.3% | ||
| Q4 24 | 86.8% | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | 21.4% | -183.1% | ||
| Q1 24 | -7.2% | -169.3% |
| Q4 25 | 2.2% | 0.3% | ||
| Q3 25 | 0.8% | 1.9% | ||
| Q2 25 | 0.6% | 0.8% | ||
| Q1 25 | 0.3% | 8.2% | ||
| Q4 24 | 0.8% | 0.6% | ||
| Q3 24 | 0.0% | 2.3% | ||
| Q2 24 | 0.6% | 0.8% | ||
| Q1 24 | 0.3% | 1.0% |
| Q4 25 | 3.55× | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.32× | — | ||
| Q1 25 | -0.49× | — | ||
| Q4 24 | 4.31× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 1.75× | — | ||
| Q1 24 | -0.69× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
